Hong Kong
· Delayed Price · Currency is HKD Hansoh Pharmaceutical Group Company Company Description
Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.
The company provides products for therapeutic areas, including anti-infection, central nervous system, oncology, and metabolic and other diseases, as well as autoimmune diseases.
Its principal products include Ameile, Hansoh Xinfu, Pulaile, Zefei, Xintai, Xinmei, Gainuo, Tanneng, and Pulaitan; Hengmu, Mailingda, Hengsen, Oulanning, Ailanning, and Ameining; XINYUE; and Saint Luolai, Fulaimei, Ruibote, Fulaidi, Fulairui, Punuoan tablets, etc. It has licence agreements with GlaxoSmithKline Intellectual Property (No.4) Limited to develop, manufacture, and commercialize HS-20089 and HS-20093 for the treatment of patients with extensive-stage small-cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy; Biotheus Inc. to develop, produce, and commercialize bispecific antibody-drug conjugate product; and with Merck Sharp & Dohme LLC (MSD) to develop, manufacture, and commercialize HS-10535, an investigational pre-clinical oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist.
The company was founded in 1995 and is headquartered in Shanghai, China. Hansoh Pharmaceutical Group Company Limited is a subsidiary of Stellar Infinity Company Ltd.
| Country | Cayman Islands |
| Founded | 1995 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 8,989 |
| CEO | Huijuan Zhong |
Contact Details
Address: 287 Xiangke Road Shanghai, 201210 China | |
| Phone | 86 40 0828 5227 |
| Website | hspharm.com |
Stock Details
| Ticker Symbol | 3692 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | KYG549581067 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Huijuan Zhong | Chairlady, Chief Executive Officer and President |
| Dr. Aifeng Lyu | Executive Director |
| Yuan Sun | Executive Director |
| Min Hu | Vice President and Chief Financial Officer |
| Dr. Shan Jiang | Chief Technology Officer |
| Dr. Chih-Hung Lee | Chief of Science Officer |
| Chuanhe Xu | Senior Vice President |
| Weiyong Sun | Chief Business Officer |
| Dr. Xiaoqing Zhang | Chief Medical Officer |
| Shengli Zhong | Joint Company Secretary and Senior Vice President |